Holen Sie sich die Stockscreener-App
2.75
12.70%
0.31
Vorhandelsmarkt:
2.70
-0.05
-1.82%
Schlusskurs vom Vortag:
$2.44
Offen:
$2.4
24-Stunden-Volumen:
118.70K
Relative Volume:
1.77
Marktkapitalisierung:
$4.20M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-23.14M
KGV:
-2.7144
EPS:
-1.0131
Netto-Cashflow:
$-29.23M
1W Leistung:
-39.02%
1M Leistung:
-62.98%
6M Leistung:
-67.84%
1J Leistung:
-77.46%
1-Tages-Spanne:
$2.40
$2.8399
1-Wochen-Bereich:
$2.31
$6.03
52-Wochen-Spanne:
$2.31
$22.06
BiomX Inc Stock (PHGE) Company Profile
Firmenname
BiomX Inc
Sektor
Branche
Telefon
972 7 23942377
Adresse
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Vergleichen Sie PHGE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
2.75 | 3.73M | 0 | -23.14M | -29.23M | -1.0131 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-04-15 | Eingeleitet | Ladenburg Thalmann | Buy |
BiomX Inc Aktie (PHGE) Neueste Nachrichten
BiomX Discontinues Phase 2b Trial for BX004 - The Globe and Mail
Healthy Upside Potential: BiomX Inc (PHGE) - Setenews
BiomX Halts Phase 2b Trial Of BX004 In Cystic Fibrosis On High Rates Of Adverse Events - Nasdaq
Stocks Tumble As Bad News Hits Biotech And Energy Sectors - Finimize
BiomX Discontinues Phase 2b Clinical Trial for BX004 - TradingView
BiomX (PHGE) Halts Phase 2b Trial and Implements Cost-Saving Str - GuruFocus
BiomX announces discontinuation of phase 2b Bx004 trial following internal review - marketscreener.com
BiomX Inc. Announces Discontinuation of Phase 2b BX004 Trial Following Internal Review - marketscreener.com
BiomX (PHGE) Price Target Increased by 964.52% to 168.30 - Nasdaq
BiomX (PHGE) Stock Analysis Report | Financials & Insights - Benzinga
Why BiomX Inc. stock could be top winner2025 Volatility Report & Precise Swing Trade Entry Alerts - Newser
How BiomX Inc. stock performs in high volatility marketsJuly 2025 Update & Daily Price Action Insights - Newser
How BiomX Inc. stock reacts to Fed tighteningJuly 2025 Update & AI Forecasted Entry/Exit Points - Newser
How BiomX Inc. stock compares with tech leadersJuly 2025 Review & Technical Pattern Alert System - Newser
How forex fluctuations impact BiomX Inc. stockWeekly Stock Recap & High Yield Equity Trading Tips - Newser
Is BiomX Inc. stock ideal for retirement investorsMarket Growth Report & Comprehensive Market Scan Reports - Newser
How BiomX Inc. stock behaves in tightening cyclesAnalyst Downgrade & Safe Entry Trade Signal Reports - Newser
BiomX provides update on BX004 Phase 2b trial in Cystic Fibrosis - MSN
BiomX announces 1-for-19 reverse stock split - MSN
H.C. Wainwright reiterates Buy rating on BiomX stock amid FDA queries By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Buy rating on BiomX stock amid FDA queries - Investing.com Canada
BiomX (NYSEAMERICAN:PHGE) Stock Price Expected to Rise, HC Wainwright Analyst Says - Defense World
HC Wainwright Issues Optimistic Estimate for BiomX Earnings - Defense World
BiomX (NYSEAMERICAN:PHGE) Price Target Raised to $26.00 at HC Wainwright - Defense World
BiomX (NYSEAMERICAN:PHGE) Given New $26.00 Price Target at HC Wainwright - Defense World
HC Wainwright Boosts BiomX (NYSEAMERICAN:PHGE) Price Target to $26.00 - Defense World
HC Wainwright & Co. Reiterates BiomX (PHGE) Buy Recommendation - Nasdaq
PHGE: HC Wainwright & Co. Reiterates Buy Rating with $26 PT | PH - GuruFocus
Why Is BiomX Stock Falling Today?BiomX (AMEX:PHGE) - Benzinga
BiomX Awaits FDA Clearance To Restart Cystic Fibrosis Trial After Nebulizer Device Review - Sahm
BiomX To Continue Cystic Fibrosis Study With Revised Dosing Of BX004; Data Expected In Q2, 2026 - Nasdaq
BiomX Says Working to Lift FDA Hold Concerning Nebulizer Device in Phase 2b Study of BX004 for Cystic Fibrosis - marketscreener.com
FDA Review Delays BiomX's (PHGE) Cystic Fibrosis Trial Progress - GuruFocus
BiomX Updates on Phase 2b Study for BX004 - TipRanks
BiomX Updates on FDA Clinical Hold and Study Progress - TradingView
BiomX (NYSE American: PHGE) DMC Backs BX004 Phase 2b Study, Topline Expected 2026 - Stock Titan
PHGE: HC Wainwright Raises Price Target for BiomX to $26.00 | PH - GuruFocus
HC Wainwright & Co. Maintains BiomX (PHGE) Buy Recommendation - Nasdaq
BiomX price target adjusted to $26 from $15 at H.C. Wainwright - TipRanks
Stock splits calendar for: - Yahoo Finance Singapore
BiomX announces FDA feedback on development pathway for BX011 - MSN
BiomX Inc. Reports Q3 2025 Financial Results and Program Updates - MSN
BiomX Inc. Earnings Call: Progress Amid Challenges - MSN
Why BiomX Inc. stock stays undervaluedJuly 2025 Trends & Precise Swing Trade Entry Alerts - newser.com
BiomX Stock to Reverse Split on Tuesday, November 25th (NYSEAMERICAN:PHGE) - Defense World
BiomX Stock to Reverse Split on Tuesday, November 25th (NYSEMKT:PHGE) - Defense World
BiomX Inc. COmmon Stock (NYSE:PHGE) Stock Quote - Markets Financial Content
Can BiomX Inc. stock retain market dominanceEarnings Recap Summary & Low Volatility Stock Recommendations - newser.com
Why BiomX Inc. stock could see breakout soonIndex Update & Proven Capital Preservation Methods - newser.com
Will BiomX Inc. stock see PE expansionJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - newser.com
Will BiomX Inc. stock extend growth storyPortfolio Profit Report & Real-Time Volume Trigger Notifications - newser.com
Finanzdaten der BiomX Inc-Aktie (PHGE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):